(Q44389803)

English

Alemtuzumab-related thyroid dysfunction in a phase 2 trial of patients with relapsing-remitting multiple sclerosis

scientific article published on 20 December 2013

Statements

Alemtuzumab-related thyroid dysfunction in a phase 2 trial of patients with relapsing-remitting multiple sclerosis (English)
Gilbert H Daniels
Anton Vladic
Vesna Brinar
Igor Zavalishin
William Valente
Pedro Oyuela
David H Margolin
Jenna Hollenstein
20 December 2013

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit